Stay updated on aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.5.3 was added to the study record, replacing the previous Revision: v3.5.2. This signals a minor administrative update to the study metadata rather than any changes to the trial content or conduct.
    Difference
    0.1%
    Check dated 2026-04-30T18:40:52.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated: v3.5.0 was removed and v3.5.2 was added.
    Difference
    0.1%
    Check dated 2026-04-16T10:43:16.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:48:44.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T11:20:35.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a Publications entry for the ADRISK trial publication (Annals of Oncology 2025) and a Study Results entry detailing 24-month outcomes. Removed Plan to Share IPD, Plan for IPD, and Product Manufactured in and Exported from the U.S. items.
    Difference
    0.9%
    Check dated 2026-02-18T04:08:00.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    A new software revision label (Revision: v3.4.2) was added, and an older government funding notice (and Revision: v3.4.1) were removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:04:42.000Z thumbnail image

Stay in the know with updates to aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page.